Paul LaViolette

Paul LaViolette

Vorstandsvorsitzender bei PULSE BIOSCIENCES, INC.

Vermögen: 2 Mio $ am 30.06.2026

68 Jahre
Health Technology
Commercial Services
Finance

Profil

Paul A. LaViolette is Co-Chairman, President & CEO at Pulse Biosciences, Inc. starting in 2025.
He is Chairman at Endotronix, Inc., CardioFocus, Inc. since 2013, and Corvia Medical, Inc. since 2012.
He is Independent Director at Edwards Lifesciences Corp.
since 2020 and Director at Direct Flow Medical, Inc., CSA Medical, Inc., Solsys Medical LLC, Coridea NC2, Inc., Soffio Medical, Inc., Axon Therapies, Inc., Bardy Diagnostics, Inc., Stimwave Technologies, Inc., and others.
He is Independent Director at Cibiem, Inc. and Managing Partner at SV Health Investors LLP and SV Health Investors LLC.
He is Director at Zerigo Health, Inc. since 2019 and Vibrato Medical, Inc. since 2021.
Former roles include Chairman & Chief Executive Officer at Stimwave LLC from 2019 to 2020, Chairman at Misonix, Inc. from 2019 to 2021, Chairman at TransEnterix, Inc. from 2012 to 2013, Chairman at Baxano Surgical, Inc. from 2012 to 2013, Chairman at SafeStitch Medical, Inc. in 2013, Chairman at Asensus Surgical, Inc. from 2013 to 2021, and Chairman at The Medical Device Manufacturers Association from 2016 to 2019.
Independent Director at Thoratec Corp.
from 2013 to 2015 and Conceptus, Inc. from 2011 to 2013.
President-USCI Division at C.
R.
Bard, Inc. (New Jersey) from 1984 to 1993.
Chief Operating Officer at Boston Scientific Corp.
from 2004 to 2008.
Other former director and principal roles include positions at Urologix, Inc., DJO Global, Inc., ValenTx, Inc., DJO Finance LLC, Percutaneous Valve Technologies, Inc., Cameron Health, Inc., Advanced Medical Technology Association, CardioKinetix, Inc., Ximedica LLC, Soluble Solutions Financial Services, Inc., Kendall International, Inc., and SCIMED Life Systems, Inc. (Minnesota).
Education includes an MBA from Boston College and undergraduate studies at Fairfield University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
08.05.2026 17’552 ( 0% ) 2 Mio $ 30.06.2026
11.05.2026 15’846 ( 0.02% ) 439 410 $ 30.06.2026

Aktive Positionen von Paul LaViolette

UnternehmenPositionBeginn
EDWARDS LIFESCIENCES CORPORATION Direktor/Vorstandsmitglied 13.07.2020
PULSE BIOSCIENCES, INC. Vorstandsvorsitzender 09.01.2025
Coridea NC2, Inc.
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Vorsitzender -
░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Paul LaViolette

UnternehmenPositionEnde
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Paul LaViolette im Detail an

Ausbildung von Paul LaViolette

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

74

Beziehungen ersten Grades

43

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen43

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Coridea NC2, Inc.

Technology Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Commercial Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Paul LaViolette